Status:

SUSPENDED

Lymphomyosot for Ankle Edema Following Fracture

Lead Sponsor:

Shaare Zedek Medical Center

Conditions:

Ankle Injuries

Fracture

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Ankle fractures are invariably complicated by severe soft-tissue swelling which can significantly prevent surgical repair (open reduction and internal fixation - ORIF) of the fractured bone for up to ...

Eligibility Criteria

Inclusion

  • 18 years of age and older
  • patients with a fracture of the ankle requiring ORIF
  • signed informed consent form.

Exclusion

  • refusal or inability to give informed consent
  • bilateral fractures of the foot or ankle, open fractures, poly-trauma, contralateral limb amputation
  • currently on anticoagulation therapy
  • clinical indication for immediate surgery.
  • ability to undergo surgery on the day of the fracture , or where soft-tissue edema was not the cause which prevented immediate surgery
  • any additional injury that prevents partial weight-bearing.
  • a concomitant fracture of another long bone in the ipsilateral leg
  • if the patient suffers from a systemic disease such as diabetes, malignant tumor, severe peripheral vasculopathy, and/or metabolic disease
  • concurrent participation in another study
  • inability to comply with the study protocol

Key Trial Info

Start Date :

February 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00884988

Start Date

February 1 2010

Last Update

February 22 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shaare Zedek Medical Center

Jerusalem, Israel, 91031